[1]
Sarhan, A.S. and Naji, A.S. 2026. Clinical Outcomes and Safety of Pembrolizumab Monotherapy in Iraqi Patients with Metastatic Lung Cancer and Renal Cell Carcinoma. Middle Eastern Cancer and Oncology Journal. 2, 2 (Jun. 2026), 59–66. DOI:https://doi.org/10.61706/MECOJ160228.